The biggest challenge in diagnosing Eosinophilic disease is that biopsies are the only way to measure the amount of Eosinophils. CEGIR have recently published a study into the promising research of 12 centres which may have established an alternative way of diagnosing and monitoring EG Eosinophilic Gastritis. For more information on the exciting possibility of tissue and blood biomarkers click here